CYP2C9 and hyperlipidemia: Gemfibrozil, which is used to treat hyperlipidemia by lowering LDL and triglyceride levels, is a potent inhibitor of CYP2C8 and CYP2C9 (Wen et al. 2001; Davidson 2006).